Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Normunity Investigational Site, Denver, Colorado Normunity Investigational Site, New Haven, Connecticut Normunity Investigational Site, Minneapolis, Minnesota Normunity Investigational Site, Maumee, Ohio Normunity Investigational Site, Philadelphia, Pennsylvania Normunity Investigational Site, Nashville, Tennessee Normunity Investigational Site, Dallas, Texas Normunity Investigational Site, San Antonio, Texas Normunity Investigational Site, Fairfax, Virginia